case report aspiration glp-1 receptor agonist anesthesia 2023 Managing patients taking glucagon-like peptide-1 Are Serious Anesthesia Risks of

Berberine and GLP-1 are fundamentally different compounds targeting distinct metabolic pathways

We also present practical implications of these glucose-lowering agents for reducing the risk of adverse cardiovascular events and progressive renal comorbidity in patients with T2D and CVD.

Full escalation schedules, unit conversions, weight loss data, and switching protocols.

This does not influence our rankings or medical evaluations

In November 2025, the Trump administration announced landmark agreements with Eli Lilly and Novo Nordisk reducing the monthly price of GLP-1 weight-loss drugs from over $1,000 to as low as $245 for eligible patients